title: Computational approaches for identifying cancer miRNA expressions.
abstract: MicroRNAs (miRNAs) play a major role in cancer development and also act as a key factor in many other diseases. In this investigation, we propose three methods for handling miRNA expressions. The first two methods determine whether a miRNA is indicating normal or cancer condition, and the third one determines how many miRNAs are supporting the cancer sample/patient. While Method 1 acts as a two-class classifier and is based on normalized average expression value, Method 2 also does the same and is based on the normalized average intraclass distance. Method 3 checks whether a miRNA belongs to the cancer class or not, provides the percentage of supporting miRNAs for a cancer patient, and is based on weighted normalized average intraclass distance. The values of the weights are determined using exhaustive search by maximizing the accuracy in training samples. The proposed methods are tested on the differentially regulated miRNAs in three types of cancers (breast, colon, and melanoma cancer). The performances of Method 1 and Method 2 are evaluated by F score, Matthews Correlation Coefficient (MCC), and plotting "1--specificity versus sensitivity" in Receiver Operating Characteristic (ROC) space and are found to be superior to the kNN and SVM classifiers for breast, colon, and melanoma cancer data sets. It is also observed that both the sensitivity and the specificity of Method 1 and Method 2 are higher than 0.5. For the same data sets, Method 3 achieved an average accuracy of more than 98% in detecting the miRNAs, supporting the cancer condition.
authors.affiliation: Center for Soft Computing Research, Indian Statistical Institute, Kolkata, India.
authors.forename: Shubhra Sankar
authors.initials: SS
authors.lastname: Ray
authors.forename: Jayanta Kumar
authors.initials: JK
authors.lastname: Pal
authors.forename: Sankar K
authors.initials: SK
authors.lastname: Pal
mesh_terms: D006801:Humans; D035683:MicroRNAs / Q000235:genetics*; D009369:Neoplasms / Q000235:genetics*; D012372:ROC Curve
chemical_list: D035683:MicroRNAs
references.citation: Cancer Res. 2005 Aug 15;65(16):7065-70
references.pmid: 16103053
references.citation: Cancer Res. 2008 Jan 15;68(2):425-33
references.pmid: 18199536
references.citation: Nature. 2000 Feb 24;403(6772):901-6
references.pmid: 10706289
references.citation: BMC Cancer. 2010 Jun 07;10:262
references.pmid: 20529253
references.citation: BMC Cancer. 2009 Oct 20;9:374
references.pmid: 19843336
references.citation: Dev Biol. 2004 Mar 15;267(2):529-35
references.pmid: 15013811
references.citation: Dev Biol. 1999 Dec 15;216(2):671-80
references.pmid: 10642801
references.citation: BMC Bioinformatics. 2010 May 18;11:257
references.pmid: 20482775
references.citation: PLoS One. 2009 Nov 25;4(11):e8003
references.pmid: 19946373
references.citation: Nature. 2005 Jun 9;435(7043):834-8
references.pmid: 15944708
references.citation: Nat Rev Cancer. 2006 Nov;6(11):857-66
references.pmid: 17060945
references.citation: IEEE Trans Biomed Eng. 2010 Jul;57(7):1547-53
references.pmid: 20199930
references.citation: Nature. 2008 Sep 4;455(7209):58-63
references.pmid: 18668040
references.citation: Science. 2004 Jan 2;303(5654):95-8
references.pmid: 14631048
references.citation: Cell. 2003 Oct 17;115(2):209-16
references.pmid: 14567918
references.citation: Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15524-9
references.pmid: 12434020
references.citation: IEEE Trans Inf Technol Biomed. 2009 Jan;13(1):67-77
references.pmid: 19129025
references.citation: Int J Cancer. 2007 Mar 1;120(5):953-60
references.pmid: 17163415
references.citation: Genome Biol. 2007;8(10):R214
references.pmid: 17922911
references.citation: Methods Mol Biol. 2006;342:139-57
references.pmid: 16957373
references.citation: Cell. 2004 Jan 23;116(2):281-97
references.pmid: 14744438